Calcified Tissue International

, Volume 77, Issue 1, pp 15–22 | Cite as

Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women

  • A. L. Lauridsen
  • P. Vestergaard
  • A. P. Hermann
  • C. Brot
  • L. Heickendorff
  • L. Mosekilde
  • E. Nexo
Article

Abstract

The major transporter of vitamin D metabolites in the circulation is the multifunctional plasma protein Gc, also known as group-specific component, Gc globulin, vitamin D–binding protein, or DBP. There are several phenotypes of Gc, and we examined the influence of Gc phenotype and Gc concentration on vitamin D status. By using isoelectric focusing we identified the Gc phenotype of 595 caucasian recent postmenopausal women enrolled into the Danish Osteoporosis Prevention Study (DOPS). We measured plasma concentration of Gc by immunonephelometry (coefficient of variation [CV] < 5%), 25-hydroxy vitamin D (25OHD) by a competitive protein-binding assay (CV 10%), and 1,25-dihydroxy-vitamin D (1,25(OH)2D) by a radioimmunoassay (CV 6–14%), and calculated index as the molar ratio of vitamin concentration divided by Gc concentration. Plasma levels of Gc, 25OHD, 25OHD index, and 1,25(OH)2D, but not 1,25(OH)2D index, differed significantly between women with different Gc phenotype, being highest in Gc1-1, intermediate in Gc1-2, and lowest in Gc2-2. In multiple regression analysis, Gc concentration was an independent predictor of 1,25(OH)2D, whereas Gc phenotype was a significant predictor of 25OHD concentration, even after adjustment for the effects of season, sunbathing habits, skin thickness, use of vitamin supplements, smoking, and body mass index (BMI). Plasma parathyroid hormone (PTH) level did not differ between Gc phenotypes. Despite the fact that more than 60% of the women with Gc phenotype Gc2-2 had plasma 25OHD levels of less than 50 nmol/L none of them had plasma PTH higher than reference limits. Bone mineral content (BMC), Bone mineral density (BMD), and bone markers did not differ between Gc phenotypes. In conclusion, plasma 1,25(OH)2D, 25OHD, and 25OHD index are related to Gc phenotype, and we speculate that the thresholds for vitamin D sufficiency differ between Gc phenotypes.

Keywords

Group-specific component Vitamin D–binding protein Gc phenotype 25-hydroxy-vitamin D 1,25-dihydroxy-vitamin D 

References

  1. 1.
    Braun, A, Bichlmaier, R, Cleve, H 1992Molecular analysis of the gene for the human vitamin-D–binding protein (group-specific component): allelic differences of the common genetic GC typesHum Genet89401406CrossRefPubMedGoogle Scholar
  2. 2.
    Lauridsen, AL, Vestergaard, P, Nexo, E 2001Mean serum concentration of vitamin D–binding protein (Gc globulin) is related to the Gc phenotype in womenClin Chem47753756PubMedGoogle Scholar
  3. 3.
    Lee, WM, Galbraith, RM 1992The extracellular actin-scavenger system and actin toxicityN Engl J Med32613351341PubMedGoogle Scholar
  4. 4.
    Baelen, H, Bouillon, R, Moor, P 1980Vitamin D–binding protein (Gc-globulin) binds actinJ Biol Chem25522702272PubMedGoogle Scholar
  5. 5.
    Kew, RR, Webster, RO 1988Gc-globulin (vitamin D–binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des ArgJ Clin Invest82364369PubMedGoogle Scholar
  6. 6.
    Schneider, GB, Benis, KA, Flay, NW, Ireland, RA, Popoff, SN 1995Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutationsBone16657662CrossRefPubMedGoogle Scholar
  7. 7.
    Yamamoto, N, Kumashiro, R 1993Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cellsJ Immunol15127942802PubMedGoogle Scholar
  8. 8.
    Daiger, SP, Schanfield, MS, Cavallisforza, LL 1975Group-specific component (Gc) proteins bind vitamin-D and 25-hydroxyvitamin-DProc Nat Acad Sci U S A7220762080Google Scholar
  9. 9.
    Lips, P 2001Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implicationsEndocr Rev22477501CrossRefPubMedGoogle Scholar
  10. 10.
    Papapoulos, SE, Clemens, TL, Sandler, LM, Fraher, J, Winer, J, O’Riordan, JL 1982The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral doseClin Sci (Lond)62427429Google Scholar
  11. 11.
    Davies, M, Heys, SE, Selby, PL, Berry, JL, Mawer, EB 1997Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone diseaseJ Clin Endocrinol Metab82209212CrossRefPubMedGoogle Scholar
  12. 12.
    Bikle, DD, Siiteri, PK, Ryzen, E, Haddad, JG 1985Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levelsJ Clin Endocrinol Metab61969975PubMedGoogle Scholar
  13. 13.
    Bikle, DD, Gee, E, Halloran, B, Kowalski, MA, Ryzen, E, Haddad, JG 1986Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D–binding proteinJ Clin Endocrinol Metab63954959PubMedGoogle Scholar
  14. 14.
    Lund, B, Sorensen, OH 1979Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish populationScand J Clin Lab Invest392330PubMedGoogle Scholar
  15. 15.
    Lauridsen, AL, Vestergaard, P, Hermann, AP, Moller, HJ, Mosekilde, L, Nexo, E 2004Female premenopausal fracture risk is associated with Gc phenotypeJ Bone Miner Res19875878PubMedGoogle Scholar
  16. 16.
    Aarskog, D, Aksnes, L, Markestad, T, Rodland, O 1983Effect of estrogen on vitamin D metabolism in tall girlsJ Clin Endocrinol Metab5711551158PubMedGoogle Scholar
  17. 17.
    Dick, IM, Prince, RL, Kelly, JJ, Ho, KK 1995Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administrationClin Endocrinol (Oxf)43219224Google Scholar
  18. 18.
    Hoof, HJ, Sevaux, RG, Baelen, H, Swinkels, LM, Klipping, C, Ross, HA, Sweep, CG 2001Relationship between free and total 1,25-dihydroxyvitamm D in conditions of modified bindingEur J Endocrinol144391396CrossRefPubMedGoogle Scholar
  19. 19.
    Bouillon, R, Auwerx, J, Dekeyser, L, Fevery, J, Lissens, W, Moor, P 1984Serum vitamin D metabolites and their binding protein in patients with liver cirrhosisJ Clin Endocrinol Metab598689PubMedGoogle Scholar
  20. 20.
    Yamamoto, N, Homma, S 1991Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytesProc Natl Acad Sci USA8885398543PubMedGoogle Scholar
  21. 21.
    Kawakami, M, Blum, CB, Ramakrishnan, R, Dell, RB, Goodman, DS 1981Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjectsJ Clin Endocrinol Metab5311101116PubMedGoogle Scholar
  22. 22.
    Van den, BG, Roosbroeck, D, Vanhove, P, Wouters, PJ, Pourcq, L, Bouillon, R 2003Bone turnover in prolonged critical illness: effect of vitamin DJ Clin Endocrinol Metab8846234632CrossRefPubMedGoogle Scholar
  23. 23.
    Bouillon, R, Baelen, H, Moor, P 1980Comparative study of the affinity of the serum vitamin D–binding proteinJ Steroid Biochem1310291034CrossRefPubMedGoogle Scholar
  24. 24.
    Boutin, B, Galbraith, RM, Arnaud, P 1989Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin DJ Steroid Biochem325963CrossRefPubMedGoogle Scholar
  25. 25.
    Arnaud, J, Constans, J 1993Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP)Hum Genet92183188CrossRefPubMedGoogle Scholar
  26. 26.
    Braun, A, Brandhofer, A, Cleve, H. 1990Interaction of the vitamin D–binding protein (group-specific component), its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusingElectrophoresis11478483CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • A. L. Lauridsen
    • 1
    • 2
  • P. Vestergaard
    • 3
  • A. P. Hermann
    • 3
  • C. Brot
    • 4
  • L. Heickendorff
    • 1
  • L. Mosekilde
    • 3
  • E. Nexo
    • 1
  1. 1.Department of Clinical Biochemistry, NBG, Aarhus SygehusAarhus University HospitalAarhusDenmark
  2. 2.Department of Clinical BiochemistryRanders CentralsygehusRandersDenmark
  3. 3.Department of Endocrinology and Metabolism CAarhus University HospitalAarhusDenmark
  4. 4.The Osteoporosis Research CenterHvidovre HospitalHvidovreDenmark

Personalised recommendations